Tessa Lühmann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tessa Lühmann has a total of 395 co-authors. Here are the top co-authors by number of shared publications:
- Lorenz Meinel
Institute for Pharmacy and Food Chemistry, University of Würzburg, Würzburg, Germany
45 shared publications Heike Hall
Cells and BioMaterials, Department of Materials, ETH Zurich, 8093 Zurich, Switzerland
11 shared publications- Marcus Gutmann
Institute for Pharmacy and Food Chemistry, University of Würzburg, Am Hubland, Würzburg, Germany, 97074
11 shared publications Marcus Gutmann
Institut for Pharmacy and Food Chemistry Universität Würzburg Am Hubland 97074 Würzburg Germany
10 shared publications- Salvador Pané
Multi‐Scale Robotics Lab (MSRL) Institute of Robotics and Intelligent Systems (IRIS) ETH Zurich Zurich CH‐8092 Switzerland
9 shared publications Lorenz Meinel
Institut for Pharmacy and Food Chemistry Universität Würzburg Am Hubland 97074 Würzburg Germany
8 shared publications
Latest Publications
- Open Access
- 17 November 2026
- Published by American Chemical Society (ACS) in ChemRxiv
A shared formulation design space reveals poly(2-ethyl-2oxazoline) chain length as a determinant of lipid nanoparticle performance and relative organ distribution
The interface between lipid nanoparticles (LNPs) and their biological environment represents a key determinant of biodistribution. Here, we investigated poly(2-ethyl-2oxazoline) (PEtOx)-lipids as an adaptable component of this interface and determined how polymer chain length affects LNP formulation as well as biological behavior. Rather than comparing different polymers with a single nominal formulation composition, we first mapped the pharmaceutical design space of four PEtOx-lipids containing average chain lengths of 20, 34, 49, or 71 repeating units and identified formulation conditions that supported acceptable LNP formation. This shared design space subsequently enabled the comparison of chain-length-dependent effects under pharmaceutically viable conditions. Increasing PEtOx chain length decreased the apparent hydrophobicity of the PEtOx-lipids and was associated with progressively smaller LNP diameters, lower mRNA encapsulation efficiencies, and a narrower formulation space in which predefined criteria for size, polydispersity, and mRNA loading were met concomitantly. Optimized PEtOx-LNPs mediated mRNA expression across multiple primary and human induced pluripotent stem cell-derived cell types with limited effects on cell viability. Pooled in vivo DNA barcoding of the PEtOx20-, PEtOx34-, and PEtOx49-LNPs revealed chain-length-dependent differences in relative organ barcode distribution, with shorter chains shifting relative distribution toward spleen and pancreas and away from bone marrow and liver. Together, these findings establish PEtOx chain length as an independent LNP design parameter and demonstrate a formulation-space-based strategy for comparing polymeric excipients without relying on a single predefined formulation composition.
- 17 November 2026
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessA shared formulation design space reveals poly(2-ethyl-2oxazoline) chain length as a determinant of lipid nanoparticle performance and relative organ distribution
The interface between lipid nanoparticles (LNPs) and their biological environment represents a key determinant of biodistribution. Here, we investigated poly(2-ethyl-2oxazoline) (PEtOx)-lipids as an adaptable component of this interface and determined how polymer chain length affects LNP formulation as well as biological behavior. Rather than comparing different polymers with a single nominal formulation composition, we first mapped the pharmaceutical design space of four PEtOx-lipids containing average chain lengths of 20, 34, 49, or 71 repeating units and identified formulation conditions that supported acceptable LNP formation. This shared design space subsequently enabled the comparison of chain-length-dependent effects under pharmaceutically viable conditions. Increasing PEtOx chain length decreased the apparent hydrophobicity of the PEtOx-lipids and was associated with progressively smaller LNP diameters, lower mRNA encapsulation efficiencies, and a narrower formulation space in which predefined criteria for size, polydispersity, and mRNA loading were met concomitantly. Optimized PEtOx-LNPs mediated mRNA expression across multiple primary and human induced pluripotent stem cell-derived cell types with limited effects on cell viability. Pooled in vivo DNA barcoding of the PEtOx20-, PEtOx34-, and PEtOx49-LNPs revealed chain-length-dependent differences in relative organ barcode distribution, with shorter chains shifting relative distribution toward spleen and pancreas and away from bone marrow and liver. Together, these findings establish PEtOx chain length as an independent LNP design parameter and demonstrate a formulation-space-based strategy for comparing polymeric excipients without relying on a single predefined formulation composition.
- Open Access
- 9 August 2026
- Published by American Chemical Society (ACS) in ChemRxiv
Programming Lipid Nanoparticle Interfaces through Function-Encoded Statistical Polymers
Poly(ethylene glycol) (PEG) is the standard stealth polymer to functionalize lipid nanoparticle (LNP) surfaces, requiring conjugation to a lipid tail for anchoring in the LNP’s shell. We eliminate the need for lipid conjugates by introducing a new polymer-only design principle using function-encoded statistical polymers. For that, we synthesized statistical amphiphilic copolymers in which hydrophobic units are followed by hydrophilic units, with the intention that the hydrophobic units of the polymer anchor to the LNP surface, and its hydrophilic parts stealth the particle surface. We screened the formulation space using a 42-member poly(2-oxazoline) library, yielding design rules for successful LNP formulations. Cryogenic transmission electron microscopy confirmed the intact LNP structure, and biological activity was assessed in multiple human cell types differentiated from inducible pluripotent stem cells. Intravenously administered barcoded LNPs formulated with function-encoded statistical polymers compared to the equivalent PEG-lipid LNPs showed 2.5- and 5-fold higher amounts in mice and lower bloodstream levels, leading to significantly higher accumulation in the spleen and liver. Rather than assembling LNP interfaces from multiple molecular components, this work establishes that orthogonal interfacial functions can be encoded directly into the architecture of a single statistical polymer, providing a general molecular design principle for programmable nanomedicine interfaces.
- 9 August 2026
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessProgramming Lipid Nanoparticle Interfaces through Function-Encoded Statistical Polymers
Poly(ethylene glycol) (PEG) is the standard stealth polymer to functionalize lipid nanoparticle (LNP) surfaces, requiring conjugation to a lipid tail for anchoring in the LNP’s shell. We eliminate the need for lipid conjugates by introducing a new polymer-only design principle using function-encoded statistical polymers. For that, we synthesized statistical amphiphilic copolymers in which hydrophobic units are followed by hydrophilic units, with the intention that the hydrophobic units of the polymer anchor to the LNP surface, and its hydrophilic parts stealth the particle surface. We screened the formulation space using a 42-member poly(2-oxazoline) library, yielding design rules for successful LNP formulations. Cryogenic transmission electron microscopy confirmed the intact LNP structure, and biological activity was assessed in multiple human cell types differentiated from inducible pluripotent stem cells. Intravenously administered barcoded LNPs formulated with function-encoded statistical polymers compared to the equivalent PEG-lipid LNPs showed 2.5- and 5-fold higher amounts in mice and lower bloodstream levels, leading to significantly higher accumulation in the spleen and liver. Rather than assembling LNP interfaces from multiple molecular components, this work establishes that orthogonal interfacial functions can be encoded directly into the architecture of a single statistical polymer, providing a general molecular design principle for programmable nanomedicine interfaces.
- Open Access
- 26 July 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (30) , e71353
3D Bioprinted Breast Cancer‐Stroma Model with Tailored Migration‐Permissive Bioink Reveals Impact of Adipose‐Derived Stromal Cells on Cancer Cell Migration and Invasion Dynamics
In breast cancer, local invasion of cancer cells into surrounding tissue marks the first step of metastasis. However, to elucidate the impact of cells from the tumor microenvironment on this process, advanced 3D migration models are still urgently needed. To enable migration and invasion studies in a fully 3D bioprinted tumor‐stroma model, a migration‐permissive bioink composed of methacrylated collagen type I and thiolated hyaluronic acid with low polymer content is developed. In a printed co‐culture model comprising metastatic breast cancer cells (MDA‐MB‐231) and adipose‐derived stromal cells (ASCs), real‐time single‐cell tracking reveals that ASCs in the stromal compartment profoundly promote migration and invasion dynamics of individual tumor cells. This is reflected by increased speed, migration distance, and invasion into the stroma, and is accompanied by collagen remodeling and a shift in tumor cell morphology. A correlation between tumor cell morphology and migration speed is evident, which is modulated by ASCs. A highly motile and invasive subset of tumor cells is significantly enhanced in the presence of ASCs. These insights into the influence of ASCs on the heterogeneity of breast cancer cells in terms of their migratory behavior may inform the development of more specific and effective treatment options for metastatic breast cancer.
- 26 July 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (30) , e71353
Open Access3D Bioprinted Breast Cancer‐Stroma Model with Tailored Migration‐Permissive Bioink Reveals Impact of Adipose‐Derived Stromal Cells on Cancer Cell Migration and Invasion Dynamics
In breast cancer, local invasion of cancer cells into surrounding tissue marks the first step of metastasis. However, to elucidate the impact of cells from the tumor microenvironment on this process, advanced 3D migration models are still urgently needed. To enable migration and invasion studies in a fully 3D bioprinted tumor‐stroma model, a migration‐permissive bioink composed of methacrylated collagen type I and thiolated hyaluronic acid with low polymer content is developed. In a printed co‐culture model comprising metastatic breast cancer cells (MDA‐MB‐231) and adipose‐derived stromal cells (ASCs), real‐time single‐cell tracking reveals that ASCs in the stromal compartment profoundly promote migration and invasion dynamics of individual tumor cells. This is reflected by increased speed, migration distance, and invasion into the stroma, and is accompanied by collagen remodeling and a shift in tumor cell morphology. A correlation between tumor cell morphology and migration speed is evident, which is modulated by ASCs. A highly motile and invasive subset of tumor cells is significantly enhanced in the presence of ASCs. These insights into the influence of ASCs on the heterogeneity of breast cancer cells in terms of their migratory behavior may inform the development of more specific and effective treatment options for metastatic breast cancer.
- Open Access
Exploring lipid nanoparticle design spaces using self-regulating microfluidic machines and multiplexed in vivo biodistribution
Delivering therapeutic mRNA relies on lipid nanoparticles (LNPs). Finding optimal process parameters for new lipid combinations in LNP formulations remains a challenge. In our work, we used an automated, self-regulating microfluidic platform that actively changes process parameters to tune LNP formulations for preset, desired quality standards. We tested new LNPs by swapping poly(ethylene glycol) (PEG) lipopolymers for alternatives based on poly(2-methyl-2-oxazoline) (PMeOx) and poly(2-ethyl-2-oxazoline) (PEtOx). For each lipopolymer variant, the platform independently identified optimal production conditions in four or fewer iterative cycles, yielding particles of the preset size and high mRNA encapsulation. Small-angle X-ray scattering revealed that smaller LNPs modified with PEtOx had more structural surface variety and higher mRNA loading efficiency. When multiplexing these formulations in mice, the PEtOx-containing LNPs accumulated more in bone marrow compared to those with PEG, indicating trends that the chemistry of the lipopolymer affects the biodistribution of the resulting LNPs. By combining automated formulation and in vivo multiplexed testing, our approach provides a practical way to rapidly plan, formulate, and evaluate large pharmaceutical design spaces, to select excipients and process parameters yielding optimal biological performance of LNPs.
Open AccessExploring lipid nanoparticle design spaces using self-regulating microfluidic machines and multiplexed in vivo biodistribution
Delivering therapeutic mRNA relies on lipid nanoparticles (LNPs). Finding optimal process parameters for new lipid combinations in LNP formulations remains a challenge. In our work, we used an automated, self-regulating microfluidic platform that actively changes process parameters to tune LNP formulations for preset, desired quality standards. We tested new LNPs by swapping poly(ethylene glycol) (PEG) lipopolymers for alternatives based on poly(2-methyl-2-oxazoline) (PMeOx) and poly(2-ethyl-2-oxazoline) (PEtOx). For each lipopolymer variant, the platform independently identified optimal production conditions in four or fewer iterative cycles, yielding particles of the preset size and high mRNA encapsulation. Small-angle X-ray scattering revealed that smaller LNPs modified with PEtOx had more structural surface variety and higher mRNA loading efficiency. When multiplexing these formulations in mice, the PEtOx-containing LNPs accumulated more in bone marrow compared to those with PEG, indicating trends that the chemistry of the lipopolymer affects the biodistribution of the resulting LNPs. By combining automated formulation and in vivo multiplexed testing, our approach provides a practical way to rapidly plan, formulate, and evaluate large pharmaceutical design spaces, to select excipients and process parameters yielding optimal biological performance of LNPs.
- Open Access
- 22 April 2026
- Published by Royal Society of Chemistry (RSC) in RSC Chemical Biology
- Vol. 7 (6) , 945-963
Strategies to overcome hepatic clearance of endogenous proteins – molecular and formulation approaches
This review examines advanced formulation and molecular engineering strategies to reduce rapid hepatic clearance of therapeutic proteins.
- 22 April 2026
- Published by Royal Society of Chemistry (RSC) in RSC Chemical Biology
- Vol. 7 (6) , 945-963
Open AccessStrategies to overcome hepatic clearance of endogenous proteins – molecular and formulation approaches
This review examines advanced formulation and molecular engineering strategies to reduce rapid hepatic clearance of therapeutic proteins.
- Open Access
- 24 November 2025
- Published by Wiley in ChemBioChem
- Vol. 26 (24) , e202500569
Dynamic Anchoring of Peptides to the Extracellular Matrix Enabled by Boronic Acid
Given the extracellular matrix (ECM) essential role in tissue development, maintenance, and repair, exploiting its glycan structures offers new opportunities for dynamic drug storage and targeted delivery of peptides via injectable solutions. This study investigates the reversible, pH–driven interaction between boronic acid‐functionalized compounds and diol‐rich glycans within cell‐derived decellularized extracellular matrices (CDMs). An N‐terminally functionalized model peptide was produced using carboxy‐phenyl‐boronic acid (CPBA), and its pH‐dependent binding to the diol‐rich structures of CDMs was demonstrated. A CPBA‐conjugated myostatin inhibitor maintained its full potency as a prerequisite for future therapeutic application. The findings suggest N‐terminally boronic acid‐modified peptides as drug candidates for targeted delivery and storage to diol‐rich glycans of the natural ECM.
- 24 November 2025
- Published by Wiley in ChemBioChem
- Vol. 26 (24) , e202500569
Open AccessDynamic Anchoring of Peptides to the Extracellular Matrix Enabled by Boronic Acid
Given the extracellular matrix (ECM) essential role in tissue development, maintenance, and repair, exploiting its glycan structures offers new opportunities for dynamic drug storage and targeted delivery of peptides via injectable solutions. This study investigates the reversible, pH–driven interaction between boronic acid‐functionalized compounds and diol‐rich glycans within cell‐derived decellularized extracellular matrices (CDMs). An N‐terminally functionalized model peptide was produced using carboxy‐phenyl‐boronic acid (CPBA), and its pH‐dependent binding to the diol‐rich structures of CDMs was demonstrated. A CPBA‐conjugated myostatin inhibitor maintained its full potency as a prerequisite for future therapeutic application. The findings suggest N‐terminally boronic acid‐modified peptides as drug candidates for targeted delivery and storage to diol‐rich glycans of the natural ECM.
- Open Access
- 1 October 2025
- Published by American Chemical Society (ACS) in ACS Central Science
- Vol. 11 (11) , 2172-2179
A Viral Neuraminidase-Specific Sensor for Taste-Based Detection of Influenza
Influenza has caused the deadliest pandemics in history, thereby prompting advances in our ability to ensure vigilance at all stages of future outbreaks. Quarantining patients early is crucial when it comes to preventing these outbreaks, but it is challenging with influenza due to presymptomatic transmission. Presymptomatic detection translates into massive screening needs, which necessitate cost-effective tools with access for anyone, anywhere, and at any time. We met these challenges by synthesizing sensors that respond to influenza infections with taste generation by using the tongue as an always-available detector. In doing so, we utilized the virus’s need for neuraminidase cleavage of α-glycosidic bonds to detect its presence in patients. We synthesized N-acetylneuraminic acid-thymol derivatives and chemically tuned them to respond to viral but not bacterial neuraminidase. Viral selectivity was further confirmed via structural analysis and molecular docking. Influenza sensors that respond to viral presence with taste may have unmatched advantages regarding accessibility and cost-effectiveness, including the potential to first-line stratify millions of healthy individuals from flu patients, thereby enabling us to leverage our response armamentarium in future outbreaks.
- 1 October 2025
- Published by American Chemical Society (ACS) in ACS Central Science
- Vol. 11 (11) , 2172-2179
Open AccessA Viral Neuraminidase-Specific Sensor for Taste-Based Detection of Influenza
Influenza has caused the deadliest pandemics in history, thereby prompting advances in our ability to ensure vigilance at all stages of future outbreaks. Quarantining patients early is crucial when it comes to preventing these outbreaks, but it is challenging with influenza due to presymptomatic transmission. Presymptomatic detection translates into massive screening needs, which necessitate cost-effective tools with access for anyone, anywhere, and at any time. We met these challenges by synthesizing sensors that respond to influenza infections with taste generation by using the tongue as an always-available detector. In doing so, we utilized the virus’s need for neuraminidase cleavage of α-glycosidic bonds to detect its presence in patients. We synthesized N-acetylneuraminic acid-thymol derivatives and chemically tuned them to respond to viral but not bacterial neuraminidase. Viral selectivity was further confirmed via structural analysis and molecular docking. Influenza sensors that respond to viral presence with taste may have unmatched advantages regarding accessibility and cost-effectiveness, including the potential to first-line stratify millions of healthy individuals from flu patients, thereby enabling us to leverage our response armamentarium in future outbreaks.
- 7 March 2025
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 11 (4) , 2435-2447
Alginate-Dialdehyde-Based Reporter Ink Enabling Online Detection of Matrix Metalloproteinase Activity of Encapsulated Cells
Biofabrication and three-dimensional (3D) bioprinting enable precise spatial arrangement of cells within biomaterial scaffolds. We developed an alginate-based and Förster resonance energy transfer (FRET)-responsive "turn-on" reporter ink platform to enable real-time monitoring of matrix metalloproteinase (MMP) activity. Three distinct MMP-cleavable turn-on peptide reporters were synthesized and characterized for their cell-specific cleavage profiles using recombinant MMPs, cell-derived media, and different cell cultures (NIH3T3, HEK293, and MelHo). All turn-on reporters were covalently and site-specifically incorporated into alginate dialdehyde (ADA) to yield an MMP reporter ink. The ADA reporter ink with an MMP 13 turn-on reporter was responsive to all tested cell types over time within the cast bulk constructs. The ADA reporter ink material blended with gelatin had comparable print resolution and structural fidelity as observed for ADA. The extrusion-based bioprinted MelHo cell grids, measuring 2 × 2 cm2 and containing 1 × 106 cells/mL, exhibited MMP activity responses comparable to those of the casted reporter ink system, with a 3-fold increase observed at 24 h. This study introduces a versatile, FRET-based alginate bioink platform for the real-time monitoring of MMP activities, expanding the toolkit to understand cellular performance in bioprinted 3D constructs.
- 7 March 2025
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 11 (4) , 2435-2447
Alginate-Dialdehyde-Based Reporter Ink Enabling Online Detection of Matrix Metalloproteinase Activity of Encapsulated Cells
Biofabrication and three-dimensional (3D) bioprinting enable precise spatial arrangement of cells within biomaterial scaffolds. We developed an alginate-based and Förster resonance energy transfer (FRET)-responsive "turn-on" reporter ink platform to enable real-time monitoring of matrix metalloproteinase (MMP) activity. Three distinct MMP-cleavable turn-on peptide reporters were synthesized and characterized for their cell-specific cleavage profiles using recombinant MMPs, cell-derived media, and different cell cultures (NIH3T3, HEK293, and MelHo). All turn-on reporters were covalently and site-specifically incorporated into alginate dialdehyde (ADA) to yield an MMP reporter ink. The ADA reporter ink with an MMP 13 turn-on reporter was responsive to all tested cell types over time within the cast bulk constructs. The ADA reporter ink material blended with gelatin had comparable print resolution and structural fidelity as observed for ADA. The extrusion-based bioprinted MelHo cell grids, measuring 2 × 2 cm2 and containing 1 × 106 cells/mL, exhibited MMP activity responses comparable to those of the casted reporter ink system, with a 3-fold increase observed at 24 h. This study introduces a versatile, FRET-based alginate bioink platform for the real-time monitoring of MMP activities, expanding the toolkit to understand cellular performance in bioprinted 3D constructs.
- 14 February 2025
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 22 (3) , 1253-1261
Designing the Aplysia punctata Arginine-Depleting Enzyme for Tumor Targeting
L-Amino acid oxidases (LAAO) deaminate amino acids to α-keto acids and generate hydrogen peroxide, a reactive oxygen species (ROS) with potential value for cancer therapy. We recombinantly expressed the LAAO from Aplysia punctata, called APIT (Cuvier 1803). The resulting wild-type APIT (APITwt) was conjugated to polyethylene glycol (APIT-PEG). Furthermore, an APIT mutant with an affibody targeting the human epidermal growth factor receptor 2 (HER2; zHER2-APIT) was genetically engineered resulting in a binding affinity KD of ∼ 2.2 nM to the HER2 receptor ectodomain. Further, we evaluated if the APIT and tumor-targeted APIT can be used as an APIT-drug conjugate by covalently amidating the lysine residues on the protein surface. However, for the HER2-targeted APIT, the affibody contains lysines as well, and amidation of these lysines could have impaired the affibody's affinity to the HER2 receptor. Therefore, we designed a lysine-free variant of the tumor-targeting part of zHER2-APIT using an in silico mutation analysis, suggesting the replacement of the lysines of the affibody by arginine or alanine. This new variant is referred to as zHER2(K-del)-APIT. To simulate a covalent drug loading to APIT and the targeting constructs, we attached biotin by amidation. Biotin-zHER2(K-del)-APIT successfully allowed binding to HER2-positive but not HER2-negative cells in vitro. The biodistribution of these novel constructs was tested in xenografted mice with a HER2-positive and negative tumor in each animal. The zHER2(K-del)-APIT lost its ability to target HER2-positive tumors despite the in vitro data suggesting otherwise. The zHER2-APIT accumulated within the HER2-positive tumors but not in the negative tumors. APIT-PEG had increased uptake in HER2-positive and negative tumors compared to APITwt, which can be attributed to a prolonged serum half-life achieved by PEGylation, due to the absence of any tumor-targeting effect. These biodistribution studies point to HER2-targeting LAAOs for cancer therapy and PEGylation increasing tumor accumulation.
- 14 February 2025
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 22 (3) , 1253-1261
Designing the Aplysia punctata Arginine-Depleting Enzyme for Tumor Targeting
L-Amino acid oxidases (LAAO) deaminate amino acids to α-keto acids and generate hydrogen peroxide, a reactive oxygen species (ROS) with potential value for cancer therapy. We recombinantly expressed the LAAO from Aplysia punctata, called APIT (Cuvier 1803). The resulting wild-type APIT (APITwt) was conjugated to polyethylene glycol (APIT-PEG). Furthermore, an APIT mutant with an affibody targeting the human epidermal growth factor receptor 2 (HER2; zHER2-APIT) was genetically engineered resulting in a binding affinity KD of ∼ 2.2 nM to the HER2 receptor ectodomain. Further, we evaluated if the APIT and tumor-targeted APIT can be used as an APIT-drug conjugate by covalently amidating the lysine residues on the protein surface. However, for the HER2-targeted APIT, the affibody contains lysines as well, and amidation of these lysines could have impaired the affibody's affinity to the HER2 receptor. Therefore, we designed a lysine-free variant of the tumor-targeting part of zHER2-APIT using an in silico mutation analysis, suggesting the replacement of the lysines of the affibody by arginine or alanine. This new variant is referred to as zHER2(K-del)-APIT. To simulate a covalent drug loading to APIT and the targeting constructs, we attached biotin by amidation. Biotin-zHER2(K-del)-APIT successfully allowed binding to HER2-positive but not HER2-negative cells in vitro. The biodistribution of these novel constructs was tested in xenografted mice with a HER2-positive and negative tumor in each animal. The zHER2(K-del)-APIT lost its ability to target HER2-positive tumors despite the in vitro data suggesting otherwise. The zHER2-APIT accumulated within the HER2-positive tumors but not in the negative tumors. APIT-PEG had increased uptake in HER2-positive and negative tumors compared to APITwt, which can be attributed to a prolonged serum half-life achieved by PEGylation, due to the absence of any tumor-targeting effect. These biodistribution studies point to HER2-targeting LAAOs for cancer therapy and PEGylation increasing tumor accumulation.